As seen with the TCR T cell model, RASA2-edited CAR T cells continued to kill target cells efficiently following repeated cancer cell exposures, whereas the control-edited CAR T cells were unable to control tumour cell growth (Fig. 3m). The gene discussed is RASA2; the disease is cancer.